<DOC>
	<DOCNO>NCT00567476</DOCNO>
	<brief_summary>This study investigate asthma-related quality life Brazilian patient use omalizumab .</brief_summary>
	<brief_title>Omalizumab Use Asthma-Related Quality Life Patients With Severe Persistent Allergic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Adrenergic Agonists</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Inclusion criterion : 12 75 yearsold screen visit . Body weight &gt; 20 kg &lt; 150 kg . Daily persistent asthma symptom . Night symptom least week . Forced expiratory volume 1 second ( FEV1 ) &gt; 40 % &lt; 80 % predict normal value continue asthma symptom . FEV1 increase &gt; 12 % baseline within 30 minute inhale ( 400 mcg ) nebulized ( 5 mg ) salbutamol . Subject take 500 mcg/day fluticasone equivalent associate longacting β2agonist . Inhaled corticosteroid longacting beta2 adrenergic agonist ( LABA ) dos remain fix last 12 week prior screen . Medical history least two episode asthma exacerbation treat systemic corticoid least one severe asthma exacerbation treat systemic corticoid hospitalization emergency room visit last 12 month prior screen . Positive skin prick test ( diameter wheal &gt; 3mm ) least one perennial aeroallergen ( dust mite , cat/dog dander , cockroach ) , subject likely expose study . Subject capable read understand asthma relate quality life questionnaire ( Juniper 's questionnaire ) . Exclusion criterion : Pregnant , nurse female subject . Female subject without current acceptable contraceptive method . Previous history allergy hypersensitivity omalizumab . Subjects prior treatment omalizumab . Subjects medical history psychiatric disorder . Subject treated systemic corticosteroid reason asthma . Subject take β2 antagonist medication last 3 month prior screen visit . Subject take protocol prohibit medication prior screen . Medical history food drug relate severe anaphylactoid reaction . Medical history antibiotic allergy . Patients include antibiotic allergic avoid entire duration study . Asthma related nonsteroidal antiinflammatory drug ( NSAID ) . Treatment exacerbation 4 week prior randomization . Other active lung disease . Medical history others uncontrolled disease 3 month prior randomization ( eg , infection , coronary heart diseases metabolic disease ) . Any history cancer . Abnormal electrocardiogram ( ECG ) , laboratory exam ( clinically significant abnormality ) , chest Xray ( CXR ) . Evidence history drug alcohol abuse . Airway infection ( eg , pneumonia , acute sinusitis ) 4 week prior screen visit . Smokers smoke history &gt; 10 packyears . Subject treat investigational drug past 30 day course trial . Subject elevate IgE level reason allergy . Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Asthma , anti-immunoglobulin E , omalizumab</keyword>
</DOC>